Top Companies in the Immuno-Oncology Assay Market 2030

Jack daniel avatar   
Jack daniel
The Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAG..

The Immuno-Oncology Assay Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector’s strengths, weaknesses, opportunities, and threats, while also considering political, economic, social, technological, environmental, and legal factors. Expert reviews of competitor strategies and recent developments provide a clearer view of regional dynamics and future market trajectories, establishing a strong foundation for strategic planning and informed investment decisions.

What will be the market size of Global Immuno-Oncology Assay Market 2030?

The Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30.

Download Free PDF Brochure: https://www.marknteladvisors.com/query/request-sample/Immuno-Oncology Assay-market.html

 Who are the top companies operating in the Global Immuno-Oncology Assay Market?

The report features prominent companies operating in the Immuno-Oncology Assay Market and the successful strategies they have adopted. It also provides detailed insights into each company’s market share and their role in driving the industry’s growth. As per MarkNtel Advisorstop companies in Immuno-Oncology Assay Market: Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others.

What is the key factor projected to fuel growth in the Global Immuno-Oncology Assay Market between 2025 and 2030?

Rising Cancer Cases Globally to Drive Immuno-Oncology Assay – The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory.

This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.

Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.

 Browse Full Research Report: https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html

Global Immuno-Oncology Assay Market - Segmentation Analysis

  • By Product & Services (Reagents and Antibodies, Testing Kits, Instruments, Consumables & Accessories, Software),

  • By Assay Type (Checkpoint Inhibitor Assays, Cytokine Profiling Assays, Protein Biomarker Assays, Genomic Sequencing and Mutational Analysis, Immune Profiling Assays, Tumour Biomarker Assays, Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)),

  • By Technology (Polymerase Chain Reaction, Immunoassay, Next-generation Sequencing, In-situ Hybridization, Flow Cytometry, Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.)), By Indication, (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Others (Bladder Cancer, Melanoma, etc.)),

  • By Application (Clinical Assay, Research & Development),

  • By End User (Hospitals, Cancer Research Centers, Specialty Cancer Clinics, Clinical Laboratories, Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.))

 How does the Global Immuno-Oncology Assay Market vary across different geography?

By Region

  • North America

  • South America

  • Europe

  • The Middle East and Africa

  • Asia-Pacific

 This Section cover detailed analysis of revenue, market share and growth rate, historical data (2020-23) and forecast (2025-2030) of the following segmentation and geography.

Inquire Before Buying, Connect with our Expertise Today: https://www.marknteladvisors.com/query/talk-to-our-consultant/immuno-oncology-assay-market.html

Comprehensive Table of Contents – Global Immuno-Oncology Assay Market Analysis and Forecast, 2030

  1. Table 1: Introduction

  2. Table 2: Executive Summary

  3. Table 3: Market Regulations, Policies & Standards

  4. Table 4: Immuno-Oncology Assay Market Size, Share & Scope, 2020-2030

  5. Table 5: Market Trends & Developments

  6. Table 6: Market Dynamics (Key Drivers, and Challenges)

  7. Table 7: Market Hotspots & Opportunities

  8. Table 8: Market Value Chain Analysis

  9. Table 9: Market Outlook, 2020-2030

  10. Table 10: Market Size & Analysis by Revenues (USD Million): 

  11. Table 11: Market Size & Forecast 2020-2030 by Segmentation

  12. Table 12: Market Size & Forecast 2020-2030 by Geography

  13. Table 13: Key Strategic Imperatives for Success & Growth

  14. Table 14: Competitor Analysis of GCC Fire Safety Equipment Companies

Key Benefits for Industry Participants and Stakeholders

  • Insight into emerging market trends and investment opportunities

  • Understanding of regional market dynamics and competitive landscapes

  • Data-driven forecasts to support strategic decision-making

  • Access to industry benchmarks for performance evaluation

  • Identification of potential risks and growth challenges

Browse More Reports:

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Nessun commento trovato